SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Wedbush Maintains Outperform on Avrobio, Lowers Price Target to $32

Wedbush maintains Avrobio (NASDAQ:AVRO) with a Outperform and lowers the price target from $43 to $32.

Benzinga · -

Wedbush maintains Avrobio (NASDAQ:AVRO) with a Outperform and lowers the price target from $43 to $32.